the truth about the prospects. EXAS is not the only company in this market. this pos will crash after the meeting. it's being propped up as funds short this thing. check out some other small pharmaceutical companies that have gone bust.
Big positive development for Exact Sciences this morning. This is precisely the news I had been hoping for since first highlighting the stock last February. The stock is trading up about 10% today alone. The company announced that it entered into an agreement with LabCorp to commercialize its colorectal cancer screening test PreGen Plus in average risk patients, significantly increasing the market size for the test (which is currently being used for high risk patients only). As part of the agreement, LabCorp will pay Exact $75 million in "upfront, milestone and performance based payments for a five year exclusive license followed by a non exclusive license for the life of the patent." The company is expected to introduce PreGen Plus in the first half of 2003.